Two out of three studies that did include analyses of adiponectin with aggressive prostate cancer stratified by BMI, found an inverse association with higher prostate cancer stage17, and fatal prostate cancer61, respectively, in obese and overweight men only. This evidence concerns the gene ADIPOQ and Familial prostate cancer.